Marinomed Biotech AG

MARI.VI · VIE
Analyze with AI
6/30/2025
3/31/2025
6/30/2024
3/31/2024
Assets
Cash & Equivalents€1€1€2
Short-Term Investments€0€0€0
Receivables€1€2€2
Inventory€0€1€1
Other Curr. Assets€0-€0€0
Total Curr. Assets€3€4€5
Property Plant & Equip (Net)€5€6€6
Goodwill€0€0€0
Intangibles€0€1€1
Long-Term Investments€0€0€0
Tax Assets€0€0€0
Other NC Assets€0€0€0
Total NC Assets€5€7€7
Other Assets€0€0€0
Total Assets€8€11€12
Liabilities
Payables€0€1€1
Short-Term Debt€3€24€1
Tax Payable€0€0€0
Deferred Revenue€0€0€0
Other Curr. Liab.€2€2€1
Total Curr. Liab.€5€27€3
LT Debt€7€5€21
Deferred Rev, NC€0€0€0
Deferred Tax Liab, NC€0€0€0
Other NC Liab.€1€0€0
Total NC Liab.€8€5€21
Other Liabilities€0€0€0
Cap. Leases€0€0€0
Total Liabilities€13€32€24
Equity
Pref Stock€0€0€0
Common Stock€2€2€2
Retained Earnings-€50-€67-€59
AOCI€0€45€0
Other Equity€43€0€45
Total Equity-€5-€21-€12
Supplemental Information
Minority Interest€0€0€0
Total Liab. & Tot. Equity€8€11€12
Net Debt€9€0€28€20
Marinomed Biotech AG (MARI.VI) Financial Statements & Key Stats | AlphaPilot